Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06280495
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2024-02-20
Brief Title:
Neoadjuvant Serplulimab Bevacizumab With FOLFOX vs FOLFOX Alone in RASBRAF WT pMMRMSS CRC Patients
Sponsor:
Organization:
Sun Yat-sen University